P-Glycoproteins represent a family of drug efflux proteins that convey
multidrug resistance to cells in which they are expressed. This pheno
me non can lower the efficacy of drugs used in chemotherapy. The stero
id progesterone has been shown to bind P-glycoproteins and inhibit the
ir drug efflux. We report that the antiprogestin RU 486 can reverse mu
ltidrug resistance in cells overexpressing the mouse mdr1 gene. Using
flow cytometry to measure inhibition of P-glycoprotein-dependent efflu
x of rhodamine 123, RU 486 was found to be considerably more effective
than progesterone and one-half as effective as verapamil. The results
suggest a valuable new use for RU 486.